The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Loratadine 10 mg Tablets



Azure Pharmaceuticals LtdPA22871/008/001

Main Information

Trade NameLoratadine 10 mg Tablets
Active SubstancesLoratadine
Dosage FormTablet
Licence HolderAzure Pharmaceuticals Ltd
Licence NumberPA22871/008/001

Group Information

ATC CodeR06AX13 loratadine

Status

License statusAuthorised
Licence Issued23/04/2021
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back